UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1992-08, Vol.262 (2), p.759

1992

Volltextzugriff (PDF)

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1997-02, Vol.280 (2), p.802

1997

Volltextzugriff (PDF)

Characterization of binding sites of a new neurotensin receptor antagonist, [ [formula omitted]]SR 142948A, in the rat brain

European journal of pharmacology, 1998-02, Vol.343 (1), p.67-77

1998

Volltextzugriff (PDF)

X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist

Bioorganic & medicinal chemistry letters, 1998-03, Vol.8 (6), p.653-658

1998

Volltextzugriff (PDF)

Demand response flexibility and flexibility potential of residential smart appliances: Experiences from large pilot test in Belgium

Applied energy, 2015-10, Vol.155, p.79-90

2015

Volltextzugriff (PDF)

Lactonization at the 17β-Position of Steroids

Synthesis (Stuttgart), 1980-01, Vol.1980 (4), p.289-291

1980

Volltextzugriff (PDF)

Steric effects in the epoxidation reaction in the steroid series. VI. Preparation and reactivity of the 3,20-diethylene ketal of 11 beta-hydroxy preg-7-ene-3,20-dione

Bulletin de la Société chimique de France, 1968-10, Vol.10, p.4171

1968

Volltextzugriff (PDF)

ChemInform Abstract: X-Ray Structural Characterization of SR 142948, a Novel Potent Synthetic Neurotensin Receptor Antagonist

ChemInform, 1998-07, Vol.29 (27), p.no-no

1998

Volltextzugriff (PDF)

A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease

Nephrology, dialysis, transplantation, 2009-05, Vol.24 (5), p.1553-1561

2009

Volltextzugriff (PDF)

ChemInform Abstract: LACTONIZATION AT THE 17β‐POSITION OF STEROIDS

Chemischer Informationsdienst, 1980-07, Vol.11 (30)

1980

Volltextzugriff (PDF)

Steric effect upon the epoxidation reaction of steroids. IV. Reactivity of 19-hydroxy-5-cholestene and 19-hydroxy-5-androstene

Bulletin de la Société chimique de France, 1968-05, Vol.5, p.2125

1968

Volltextzugriff (PDF)

Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators

The Journal of immunology (1950), 2018-07, Vol.201 (1), p.215-229

2018

Volltextzugriff (PDF)

Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage

Proceedings of the National Academy of Sciences - PNAS, 2018-05, Vol.115 (22), p.5798-5803

2018

Volltextzugriff (PDF)

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France

Nephrology, dialysis, transplantation, 2006-02, Vol.21 (2), p.411-418

2006

Volltextzugriff (PDF)

Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease

Nephrology, dialysis, transplantation, 2007-11, Vol.22 (11), p.3246-3254

2007

Volltextzugriff (PDF)

Expression of the atypical chemokine receptor ACKR4 identifies a novel population of intestinal submucosal fibroblasts that preferentially expresses endothelial cell regulators1

The Journal of immunology (1950), 2018-05, Vol.201 (1), p.215-229

2018

Volltextzugriff (PDF)

Granulomatous interstitial nephritis: A retrospective study of 44 cases

La revue de medecine interne, 2010-10, Vol.31 (10), p.670-676

2010

Volltextzugriff (PDF)

Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients

Nephrology, dialysis, transplantation, 2004-04, Vol.19 (4), p.898-903

2004

Volltextzugriff (PDF)

Granulomatoses rénales : étude rétrospective de 44 observations

La revue de medecine interne, 2010-10, Vol.31 (10), p.670-676

2010

Volltextzugriff (PDF)

Preparation of enantiomerically pure 1,3-anti-diols by sequential ruthenium-mediated asymmetric hydrogenation reactions

ARKIVOC, 2007-01, Vol.2007 (10), p.94-106

2007

Volltextzugriff (PDF)

Arrêt ou refus de dialyse : la situation en France

Néphrologie & thérapeutique, 2011-09, Vol.7 (5), p.273-273

2011

Volltextzugriff (PDF)

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study

International journal of clinical practice (Esher), 2006-12, Vol.60 (12), p.1687-1696

2006

Volltextzugriff (PDF)

Preparation of Enantiomerically Pure 1,3-anti-Diols by Sequential Ruthenium-Mediated Asymmetric Hydrogenation Reactions

ARKIVOC free online journal of organic chemistry, 2007 (8), p.94-106

2007

Volltextzugriff (PDF)

Incidence et évaluation des traitements de suppléance de l'insuffisance rénale chronique dans sept régions françaises en 2003: Numéro thématique. L'insuffisance rénale chronique

Bulletin epidémiologique hebdomadaire (Paris, France), 2005 (37-38), p.188-190

2005

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(18)
Französisch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist

Characterization of binding sites of a new neurotensin receptor antagonist, [ [formula omitted]]SR 142948A, in the rat brain

X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist

Demand response flexibility and flexibility potential of residential smart appliances: Experiences from large pilot test in Belgium

Lactonization at the 17β-Position of Steroids

Steric effects in the epoxidation reaction in the steroid series. VI. Preparation and reactivity of the 3,20-diethylene ketal of 11 beta-hydroxy preg-7-ene-3,20-dione

ChemInform Abstract: X-Ray Structural Characterization of SR 142948, a Novel Potent Synthetic Neurotensin Receptor Antagonist

A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease

ChemInform Abstract: LACTONIZATION AT THE 17β‐POSITION OF STEROIDS

Steric effect upon the epoxidation reaction of steroids. IV. Reactivity of 19-hydroxy-5-cholestene and 19-hydroxy-5-androstene

Expression of the Atypical Chemokine Receptor ACKR4 Identifies a Novel Population of Intestinal Submucosal Fibroblasts That Preferentially Expresses Endothelial Cell Regulators

Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France

Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease

Expression of the atypical chemokine receptor ACKR4 identifies a novel population of intestinal submucosal fibroblasts that preferentially expresses endothelial cell regulators1

Granulomatous interstitial nephritis: A retrospective study of 44 cases

Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients

Granulomatoses rénales : étude rétrospective de 44 observations

Preparation of enantiomerically pure 1,3-anti-diols by sequential ruthenium-mediated asymmetric hydrogenation reactions

Arrêt ou refus de dialyse : la situation en France

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study

Preparation of Enantiomerically Pure 1,3-anti-Diols by Sequential Ruthenium-Mediated Asymmetric Hydrogenation Reactions

Incidence et évaluation des traitements de suppléance de l'insuffisance rénale chronique dans sept régions françaises en 2003: Numéro thématique. L'insuffisance rénale chronique

Suchergebnisse filtern